US 12,070,507 B2
Complexes and methods of reducing inflammation
Kara Lorraine Spiller, Glenside, PA (US); Amanda Elizabeth Pentecost, Blackwood, NJ (US); and Yury Gogotsi, Ivyland, PA (US)
Assigned to Drexel University, Philadelphia, PA (US)
Filed by Drexel Univeristy, Philadelphia, PA (US)
Filed on Mar. 3, 2022, as Appl. No. 17/653,304.
Application 16/802,219 is a division of application No. 15/945,903, filed on Apr. 5, 2018, abandoned.
Application 17/653,304 is a continuation of application No. 16/802,219, filed on Feb. 26, 2020, abandoned.
Claims priority of provisional application 62/482,041, filed on Apr. 5, 2017.
Prior Publication US 2022/0184226 A1, Jun. 16, 2022
Int. Cl. A61K 47/69 (2017.01); A61K 31/573 (2006.01); A61K 47/52 (2017.01); A61P 29/00 (2006.01)
CPC A61K 47/6923 (2017.08) [A61K 31/573 (2013.01); A61K 47/52 (2017.08); A61K 47/6929 (2017.08); A61P 29/00 (2018.01)] 8 Claims
OG exemplary drawing
 
1. A method of reducing inflammation in a patient, comprising administering a composition comprising octadecylamine surface-functionalized nanodiamonds, wherein the surface functionalized nanodiamonds do not bind a substantial amount of a therapeutic agent, wherein the surface-functionalized nanodiamonds have a particle size of between about 1 to about 10 μm in diameter.